4//SEC Filing
Sage Therapeutics, Inc. 4
Accession 0001562180-15-000660
CIK 0001597553operating
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 11:21 AM ET
Size
8.6 KB
Accession
0001562180-15-000660
Insider Transaction Report
Form 4
Anderson Thomas
See Remarks
Transactions
- Sale
Common Stock
2015-08-10$65.34/sh−1,300$84,942→ 0 total - Sale
Common Stock
2015-08-10$67.66/sh−3,480$235,457→ 2,520 total - Sale
Common Stock
2015-08-10$67.14/sh−1,220$81,911→ 1,300 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $67.29 USD to $68.29 USD. The price reported above reflects the weighted average sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $67.045 USD to $67.28 USD. The price reported above reflects the weighted average sale price.
- [F4]This transaction was executed in multiple trades at prices ranging from $65.21 USD to $66.20 USD. The price reported above reflects the weighted average sale price.
Documents
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001597553
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 11:21 AM ET
- Size
- 8.6 KB